Cost-effectiveness of ceftolozane/tazobactam compared with piperacillin/tazobactam as empiric therapy based on the in-vitro surveillance of bacterial isolates in the United States for the treatment of complicated urinary tract infections

BACKGROUND: A challenge in the empiric treatment of complicated urinary tract infection (cUTI) is identifying the initial appropriate antibiotic therapy (IAAT), which is associated with reduced length of stay and mortality compared with initial inappropriate antibiotic therapy (IIAT). We evaluated t...

Descripción completa

Detalles Bibliográficos
Autores principales: Kauf, Teresa L, Prabhu, Vimalanand S., Medic, Goran, Borse, Rebekah H., Miller, Benjamin, Gaultney, Jennifer, Sen, Shuvayu S., Basu, Anirban
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5410095/
https://www.ncbi.nlm.nih.gov/pubmed/28454524
http://dx.doi.org/10.1186/s12879-017-2408-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5410095/
https://www.ncbi.nlm.nih.gov/pubmed/28454524
http://dx.doi.org/10.1186/s12879-017-2408-7

Ejemplares similares